Multiple myeloma: a multifactorial problem for the hand surgeon as a patient.
Al-Qattan
M M
MM
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000628:therapy; D006225:Hand / Q000294:innervation* / Q000601:surgery*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000628:therapy; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis* / Q000628:therapy; D009784:Occupational Diseases / Q000175:diagnosis* / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D010815:Physician Impairment; D014750:Vincristine / Q000008:administration & dosage / Q000633:toxicity
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine